[
  {
    "ts": null,
    "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of August 10",
    "summary": "A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read the full list for the week of August 10, 2025 -- here on Seeking Alpha.",
    "url": "https://finnhub.io/api/news?id=d3328f7322da5e3893bf572815a85939fa978cabae6f64d3ced8fdd259c3dc94",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754676459,
      "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of August 10",
      "id": 136273781,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
      "related": "ABT",
      "source": "SeekingAlpha",
      "summary": "A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read the full list for the week of August 10, 2025 -- here on Seeking Alpha.",
      "url": "https://finnhub.io/api/news?id=d3328f7322da5e3893bf572815a85939fa978cabae6f64d3ced8fdd259c3dc94"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories stock outperforms competitors on strong trading day",
    "summary": "Abbott Laboratories stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=e2b842ea5e2571fa55b9d1aabfa5335a8cc55488036cd4c90c8fd6b7ce2d7ff3",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754670720,
      "headline": "Abbott Laboratories stock outperforms competitors on strong trading day",
      "id": 136296869,
      "image": "",
      "related": "ABT",
      "source": "MarketWatch",
      "summary": "Abbott Laboratories stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=e2b842ea5e2571fa55b9d1aabfa5335a8cc55488036cd4c90c8fd6b7ce2d7ff3"
    }
  },
  {
    "ts": null,
    "headline": "Abbott's EPD Growth Beats Market Trends: Here's How to Play the Stock",
    "summary": "Abbott outpaces market trends as EPD sales surge, fueled by double-digit growth, biosimilar approvals and strong product demand.",
    "url": "https://finnhub.io/api/news?id=81404eea55a3f2d53c7745ab8cf969aa59f2226e14b2dbfb461cb088f20d4d08",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754660340,
      "headline": "Abbott's EPD Growth Beats Market Trends: Here's How to Play the Stock",
      "id": 136273688,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott outpaces market trends as EPD sales surge, fueled by double-digit growth, biosimilar approvals and strong product demand.",
      "url": "https://finnhub.io/api/news?id=81404eea55a3f2d53c7745ab8cf969aa59f2226e14b2dbfb461cb088f20d4d08"
    }
  },
  {
    "ts": null,
    "headline": "Hologic's Diagnostics Arm Set for Long-Term Upside: What's Behind It?",
    "summary": "HOLX's Diagnostics arm eyes long-term growth with new assays, platform expansion and oncology test adoption despite headwinds.",
    "url": "https://finnhub.io/api/news?id=8df2967993ccaba27de452a17584b35aedf13d852173aca45f61e3cedb8ce6e3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754656980,
      "headline": "Hologic's Diagnostics Arm Set for Long-Term Upside: What's Behind It?",
      "id": 136266976,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "HOLX's Diagnostics arm eyes long-term growth with new assays, platform expansion and oncology test adoption despite headwinds.",
      "url": "https://finnhub.io/api/news?id=8df2967993ccaba27de452a17584b35aedf13d852173aca45f61e3cedb8ce6e3"
    }
  },
  {
    "ts": null,
    "headline": "Gauzy Ltd. Announces Board of Directors Changes Following Annual Meeting",
    "summary": "Gauzy Pleased to Announce Alejandro Weinstein, Former Director in Gauzy, Elected to Board; A Long-Time Investor and Shareholder Engaged with the Company Since 2016 Gauzy Adopts Leaner Board to Reduce Corporate Expenses and Maintain Agility TEL AVIV, Israel, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Gauzy Ltd. (Nasdaq: GAUZ) (“Gauzy” or the “Company”), a global leader in vision and light control technologies, today announced changes to its Board of Directors following the Company's annual general meeting",
    "url": "https://finnhub.io/api/news?id=eec226c591e117870406a9c16fbe4d2bc0eebc4476d104b8713bff9ec8be358d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754654160,
      "headline": "Gauzy Ltd. Announces Board of Directors Changes Following Annual Meeting",
      "id": 136266645,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Gauzy Pleased to Announce Alejandro Weinstein, Former Director in Gauzy, Elected to Board; A Long-Time Investor and Shareholder Engaged with the Company Since 2016 Gauzy Adopts Leaner Board to Reduce Corporate Expenses and Maintain Agility TEL AVIV, Israel, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Gauzy Ltd. (Nasdaq: GAUZ) (“Gauzy” or the “Company”), a global leader in vision and light control technologies, today announced changes to its Board of Directors following the Company's annual general meeting",
      "url": "https://finnhub.io/api/news?id=eec226c591e117870406a9c16fbe4d2bc0eebc4476d104b8713bff9ec8be358d"
    }
  },
  {
    "ts": null,
    "headline": "Mairs & Power Balanced Fund Q2 2025 Commentary",
    "summary": "The Fund underperformed its benchmark by 2.77% due to equity underperformance. Click here to read more.",
    "url": "https://finnhub.io/api/news?id=25f4664424a05ac963a6f4bcdf80803548ad46c02afeebc02e19915edd411706",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754626500,
      "headline": "Mairs & Power Balanced Fund Q2 2025 Commentary",
      "id": 136265039,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1310052459/image_1310052459.jpg?io=getty-c-w1536",
      "related": "ABT",
      "source": "SeekingAlpha",
      "summary": "The Fund underperformed its benchmark by 2.77% due to equity underperformance. Click here to read more.",
      "url": "https://finnhub.io/api/news?id=25f4664424a05ac963a6f4bcdf80803548ad46c02afeebc02e19915edd411706"
    }
  }
]